NantHealth NantHealth Q1 Revenues Decline 11 Percent NantHealth reported a net loss of $15.4 million during the quarter, as sequencing and molecular analysis revenues fell to just $3,000. NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date The firm won't have to pay off its unsecured convertible notes until 2026 to investors, including Patrick Soon-Shiong's Nant Capital. NantHealth Q4 Revenues Flat From Year Ago The firm posted total software-related revenues of $18.6 million, up 1 percent from $18.4 million in Q4 2019. NantHealth Q3 Revenues Tick Up Slightly The health IT and precision oncology arm of Patrick Soon-Shiong's NantWorks conglomerate narrowed its quarterly net loss by 32 percent during the quarter. NantHealth Q2 Revenues Decline 12 Percent NantHealth's net loss more than tripled in the second quarter, though it continues to build up its cash reserves. May 26, 2020 NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services May 7, 2020 NantHealth Q1 Revenues Decline 10 Percent Feb 29, 2020 NantHealth Q4 Revenues Grow 6 Percent Nov 19, 2019 Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear Premium Nov 12, 2019 FDA Clears NantHealth Tumor-Normal Whole-Exome Test Nov 7, 2019 NantHealth Q3 Revenues Increase Marginally Aug 8, 2019 NantHealth Q2 Revenues Grow 17 Percent May 9, 2019 NantHealth Q1 Revenues Increase 6 Percent Mar 29, 2019 NantHealth Slows Cash Burn While Still Trying to Solve 'Reimbursement Conundrum' Premium Mar 28, 2019 NantHealth Q4 Revenues Increase 3 Percent Jan 18, 2019 NantHealth Receives Nasdaq Delisting Notice Nov 16, 2018 NantHealth Q3 Revenues Grow 2 Percent as Reimbursement Issues Frustrate Sep 7, 2018 People in the News: Nikko Khazana, Mark Mozley, Steven Kafka, More Aug 24, 2018 People in the News: John Quackenbush, Paul Holt, Marty Weems Aug 9, 2018 NantHealth Q2 Revenues Drop 6 Percent May 9, 2018 NantHealth Reports 17 Percent Revenue Growth in Q1 Mar 14, 2018 NantHealth Q4 Revenues Rise 25 Percent Feb 12, 2018 NantHealth Submits GPS Cancer Test to FDA, Debuts AI Platform for Tumor ID Premium Dec 4, 2017 UCSF, NantHealth Team on Metastatic Breast Cancer Study Nov 9, 2017 NantHealth Q3 Revenues Rise 5 Percent Load More Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.